These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31379947)

  • 21. Evaluation of imipenem 1.5 g daily in febrile patients with short duration neutropenia after chemotherapy for non-leukemic hematologic malignancies and solid tumors: personal experience and review of the literature.
    Jourdan E; Defez C; Topart D; Richard B; Bellabas H; Fabbro-Peray P; Jourdan J; Sotto A
    Leuk Lymphoma; 2003 Apr; 44(4):619-26. PubMed ID: 12769338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.
    Wojenski DJ; Barreto JN; Wolf RC; Tosh PK
    Clin Ther; 2014 Jun; 36(6):976-81. PubMed ID: 24832560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of Common Bacterial and Fungal Pathogens in Children with Hematological Malignancies during Febrile Neutropenia: Single Center Egyptian Study.
    Hagag AA; Hassan SM; Elgamasy MA; Afifi IK
    Infect Disord Drug Targets; 2016; 16(1):54-62. PubMed ID: 26715443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
    Shinohara A; Yoshiki Y; Masamoto Y; Hangaishi A; Nannya Y; Kurokawa M
    Leuk Lymphoma; 2013 Apr; 54(4):794-8. PubMed ID: 22978686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study.
    Oyake T; Takemasa-Fujisawa Y; Sugawara N; Mine T; Tsukushi Y; Hanamura I; Fujishima Y; Aoki Y; Kowata S; Ito S; Ishida Y
    Ann Hematol; 2019 May; 98(5):1209-1216. PubMed ID: 30824955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of early lymphopenia on the risk of febrile neutropenia and hematological toxicity].
    Ben Nasr S; Zriba S; Kacem K; Yahyaoui Y; El Benna H; Mansouri R; Ben Lakhal R; Meddeb B
    Tunis Med; 2015 May; 93(5):283-6. PubMed ID: 26578043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview of the Management of the Most Important Invasive Fungal Infections in Patients with Blood Malignancies.
    Shariati A; Moradabadi A; Chegini Z; Khoshbayan A; Didehdar M
    Infect Drug Resist; 2020; 13():2329-2354. PubMed ID: 32765009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of the value of colony stimulating factors for prophylaxis of febrile neutropenic episodes in adult patients treated for haematological malignancies.
    Levenga TH; Timmer-Bonte JN
    Br J Haematol; 2007 Jul; 138(2):146-52. PubMed ID: 17593021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum: Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study.
    Magira EE; Chemaly RF; Jiang Y; Tarrand J; Kontoyiannis DP
    Open Forum Infect Dis; 2019 Nov; 6(11):ofz458. PubMed ID: 31777755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.
    Mikulska M; Averbuch D; Tissot F; Cordonnier C; Akova M; Calandra T; Ceppi M; Bruzzi P; Viscoli C;
    J Infect; 2018 Jan; 76(1):20-37. PubMed ID: 29079323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of higher plasma interleukin-6 levels in patients with febrile neutropenia.
    Karan MA
    Arch Med Res; 2002; 33(6):557-61. PubMed ID: 12505102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
    Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
    Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.
    Karthaus M; Hentrich M
    Mycoses; 2011 Jan; 54 Suppl 1():1-6. PubMed ID: 21126265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteremia during neutropenia is a predictive factor for invasive fungal infection in children.
    Sano H; Kobayashi R; Suzuki D; Kishimoto K; Yasuda K; Kobayashi K
    Pediatr Int; 2013 Apr; 55(2):145-50. PubMed ID: 23253211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia.
    Verlinden A; Jansens H; Goossens H; van de Velde AL; Schroyens WA; Berneman ZN; Gadisseur AP
    Eur J Haematol; 2014 Oct; 93(4):302-8. PubMed ID: 24750350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
    Baskaran ND; Gan GG; Adeeba K
    Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis.
    Blijlevens NM; Logan RM; Netea MG
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i36-40. PubMed ID: 19372181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
    Chong Y; Yakushiji H; Ito Y; Kamimura T
    Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.